| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8447477 | European Journal of Cancer | 2011 | 6 Pages |
Abstract
Strong expression of the central microRNA biosynthesis enzyme Dicer predicts poor prognosis in patients with colorectal cancer. This is in line with investigations on prostate cancer. Contradictory, in breast, lung and ovary cancer Dicer has been shown to be a marker of good prognosis. Further studies on the cellular functions of Dicer need to address these issues.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
C. Faber, D. Horst, F. Hlubek, T. Kirchner,